Cellular redox signalling is mediated by the post-translational modification of proteins by reactive oxygen/ nitrogen species or the products derived from their reactions. In the case of oxidized lipids, several receptordependent and -independent mechanisms are now emerging. At low concentrations, adaptation to oxidative stress in the vasculature appears to be mediated by induction of antioxidant defences, including the synthesis of the intracellular antioxidant glutathione. At high concentrations apoptosis occurs through mechanisms that have yet to be defined in detail. Recent studies have revealed a mechanism through which electrophilic lipids, formed as the reaction products of oxidation, orchestrate these adaptive responses in the vasculature. Using a proteomics approach, we have identified a subset of proteins in cells that we term the electrophileresponsive proteome. Electrophilic modification of thiol groups in these proteins can initiate cell signalling events through the transcriptional activation of genes regulated by consensus sequences for the antioxidant response element found in their promoter regions. The insights gained from our understanding of the biology of these mechanisms will be discussed in the context of cardiovascular disease.
Introduction
Oxidized lipids play an integral role in the pathogenesis of atherosclerosis, in which the production of reactive oxygen and nitrogen species (ROS/RNS) in the vasculature leads to oxidation of low-density lipoprotein (LDL) [1] [2] [3] . The responses of the endothelium, neutrophils and vascular smooth muscle cells to these oxidation products are thought to contribute to the development of the atherosclerotic process [4] [5] [6] . The initial concept, central to the oxidative hypothesis for atherosclerosis, focused on the post-translational modification of the apoB (apolipoprotein B) protein and its conversion into a form recognized by the macrophage scavenger receptor [7] . With the advent of sophisticated analytical techniques to identify the wide variety of chemically distinct species found in oxidized LDL (oxLDL), it was soon appreciated that biologically active lipid oxidation products could elicit specific cellular responses distinct from unoxidized lipids. It was soon recognized that post-translational modification of proteins within vascular cells can initiate signal transduction pathways through mechanisms that are only now being defined in detail.
Activation of multiple intracellular signalling cascades in response to oxidized lipids involves both receptor-dependent and -independent mechanisms, resulting in diverse cellular responses such as antioxidant induction, cell proliferation, cell adhesion and apoptosis [6, [8] [9] [10] . Some of these responses have been shown to lead to vascular dysfunction, but more recently it has been shown that cytoprotective pathways are also activated, allowing the cells to adapt to and resist further oxidative stress [9, 11] . Defining the molecular mechanisms that lead to cytoprotection distinct from those that contribute to vascular dysfunction is now a major objective in vascular biology. Such studies may give insight into the 'exercise paradox', in which it appears that although regular exercise is associated with a decreased risk of developing atherosclerosis, exercise itself induces an oxidative stress [12] . In this short overview, the insights into the mechanisms of redox signalling in endothelial cells which lead to adaptation and protection from apoptosis will be contrasted with those that promote cell death. It is hypothesized that these signalling pathways are controlled by the reactivity of critical cysteine residues with lipid oxidation products. In this context, we define this subset of proteins as the electrophileresponsive proteome and discuss its biological implications.
Formation of oxidized lipids
The enzymic formation of oxidized lipids involves the stereospecific addition of molecular oxygen to a PUFA (polyunsaturated fatty acid). For example, prostaglandins (PGs) and leukotrienes are formed by cyclo-oxygenases and lipoxygenases metabolizing arachidonic acid. Cyclo-oxygenase 1, a haem-containing enzyme, uses molecular oxygen to convert arachidonic acid into PGG 2 and PGH 2 , which are highly unstable and are transformed into a variety of bioactive products, including PGE 2 , PGD 2 , PGF 2 , thromboxane A 2 and prostacyclin, which play an integral role in the inflammatory response [13] . Similarly, the lipoxygenases control the lipid peroxidation reaction to form hydroperoxide products that can then be converted into the highly active leukotrienes, which also play a role in the inflammatory response [14] . Both cyclo-oxygenase and lipoxygenases require that low levels of lipid peroxide are already present in PUFAs to catalyse their reactions.
It has recently been recognized that the non-enzymic oxidation of PUFA results in products that are structural analogues of those that are formed enzymically [15] . It is important to recognize that the uncontrolled lipid peroxidation leads to the loss of stereospecificity while forming a mixture of diverse products. It is interesting to note that during the peroxidation process the PUFA is converted from a lipid peroxide into an electrophile ( Figure 1 ). The decomposition of the lipid peroxides most likely occurs through mechanisms dependent on trace levels of transition metals, such as copper and iron from haem proteins [16] . The biological significance of this reaction was first discovered from the non-enzymic decomposition of arachidonic acid to form the family of compounds known as the isoprostanes [17] . Interestingly, specific isoprostanes have been isolated Serves as a sensor [46] for oxidative stress from urine and plasma and their biological properties assessed. It is now clear that, in addition to being markers of oxidative stress and antagonists of the action of PGs, they may also exert unique biological effects [18] . Notable examples include vasoconstriction in the kidney after traumatic release of myoglobin into the circulation in a process known as rhabdomyolosis, and the ability of 8-epi-PGF 2α to induce pulmonary vasoconstriction [19, 20] . Conversion of an oxidized lipid to a potent electrophile can also result from the metabolism of the primary cyclooxygenase and lipoxygenase peroxidation products. One example is the well-studied molecule 15d-PGJ 2 (15-deoxy-12,14 -PGJ 2 ), which is a by-product of the enzymic metabolism of arachidonic acid [21] . Interestingly, this compound is perhaps best known for its properties as a PPARγ (peroxisome-proliferator-activated receptor γ ) agonist, where it plays a role in cell growth and glucose homoeostasis [22] . Furthermore, this electrophilic cyclopentenone PG has been shown to function through both receptor-dependent and -independent mechanisms. Electrophilic lipids such as the cyclopentenones or aldehydes are highly reactive and can form adducts with proteins containing nucleophilic centres, particularly cysteine residues (Table 1 ). This reaction is dependent on both the reactivity of the nucleophilic centre and the electrophilic lipid involved. In proteins where the local environment can result in a thiol with a lower pK a , its enhanced activity as a nucleophile results in a greater degree of modification after exposure to a lipid-derived electrophile. The reactivity of thiols is also governed by steric factors, allowing for biological specificity to be conferred to individual proteins involved in a variety of regulated processes and signalling cascades. It is also likely that these reactive thiol groups in proteins play a significant functional role for enzyme catalysis, the binding of cofactors or interactions with other proteins. Through these mechanisms the biological consequences of protein modification will be dependent on the functional significance of the thiols that are modified.
The electrophile-responsive proteome and adaptation to stress
Not surprisingly, the cellular response to oxidized lipids depends on the concentration and extent of oxidation. Lower concentrations and moderately oxidized lipids do not induce cell death, but instead initiate an adaptive response to the stress of a subsequent exposure to ROS/RNS. This process requires the transcriptional regulation of antioxidant genes and, as we have recently shown, complex I of the respiratory chain [23] . These include enzymes related to GSH metabolism and haem oxygenase I. Higher concentrations or extensively oxidized lipids induce apoptosis. An example of such an adaptive response is shown in the experiment described in Figure 2 , where pre-treatment with 15d-PGJ 2 protects the cells from 4-hydroxynonenal (HNE)-induced apoptosis. In this study, endothelial cells were treated with non-cytotoxic concentrations of the electrophilic cyclopentenone 15d-PGJ 2 for 24 h, after which they were then exposed to a cytotoxic concentration of HNE and apoptosis was measured (Figure 2 ) [24] . This anti-apoptotic effect occurs through a mechanism in which oxLDL and specific electrophilic lipids such as 15d-PGJ 2 have been shown to induce antioxidant defences in endothelial cells, including GSH, haem oxygenase, NADH: ubiquinone oxidoreductase and nitric oxide synthase (NOS) [24, 25] . Glutamate-cysteine ligase (GCL: the rate-limiting enzyme in GSH synthesis) and haem oxygenase I genes both contain consensus sequences for antioxidant response elements (AREs) in the promoter regions, which are responsive to electrophilic compounds such as 15d-PGJ 2 [26, 27] . Electrophilic lipids activate the ARE by reacting with the thiol groups in cysteine residues of proteins upstream of ARE activation. Some examples of modulators of the ARE include the heterodimeric binding of Nrf2 (nuclear factor-erythroid-2-related factor) and other factors such as small Maf proteins originally isolated from a spontaneous musculoaponeurotic fibrosarcoma in chicken [28, 29] that is bound to the actin cytoskeleton [29] . Keap-1 has many conserved cysteines, four of which are thought to be especially reactive and are susceptible to modification by electrophiles which could allow for the dissociation of Nrf2 and its translocation to the nucleus [30] . Recently, our group has shown that 15d-PGJ 2 can modify thiols in Keap-1, which facilitates the release of Nrf2 from Keap-1 and the subsequent migration of Nrf2 into the nucleus. As expected the cell contains a sub-proteome of thiols susceptible to modification by electrophiles such as 15d-PGJ 2 ( Table 1) .
One of the key features of the atherosclerotic process is endothelial cell apoptosis [31] . There is currently debate in the literature over the apoptotic effects of oxidized lipids in the vasculature. This discrepancy in the effects of oxidized lipids on apoptosis arises from the wide-ranging in vitro models employed to test these effects. It has previously been demonstrated in endothelial cells that subconfluency and serum deprivation decreases the concentration of oxidized lipids required to induce apoptosis [9] . The presence of antioxidants, particularly GSH, also plays a key role in determining the concentration of oxidized lipids required to induce cell death. For example, it has been shown in cell culture that depletion of GSH will increase the toxicity of both oxLDL and 15d-PGJ 2 [9, 24] . It has also been shown that the presence of GSH can reverse endothelial dysfunction and lead to improved nitric oxide bioavailability [32] . In humans it has recently been discovered that a polymorphism in the GCL modifier gene is linked to myocardial infarction [33] .
The antioxidant paradox
Historically, it has been thought that oxidized lipids in any concentration are cytotoxic, leading to the hypothesis that antioxidant therapy would prevent the development and the progression of atherosclerosis. While this hypothesis is supported by animal studies, the results from clinical antioxidant trials have been inconclusive [34] . This could have arisen for a number of reasons, including a failure to link the dosing of the antioxidant to a pharmacological effect. This is demonstrated in the various clinical trials using vitamin E, in which concentrations of less than 400 units (the average dose) are ineffective whereas increased doses between 400 and 800 units are associated with a decrease in the risk of cardiovascular disease [35] . An additional factor, discussed above, is that low levels of oxidized lipids may play a role in how cells adapt to a more severe oxidative stress (Figure 3) .
For example, low concentrations of oxidized lipids can initiate cytoprotective responses [9, 11, 24] . Exercise leads to low levels of lipid peroxidation, and the formation of electrophilic oxidized lipids including aldehydes and F 2α -isoprostanes [36] . It is interesting to speculate that the increased levels of oxidized lipids generated by exercise induce an adaptive response in the vasculature, protecting it from oxidative stress. Increasing the duration and daily amount of exercise tends to increase the endogenous production of antioxidants. This is demonstrated by LDL isolated from chronic conditioned athletes which has a reduced susceptibility to oxidation when compared with LDL isolated from those beginning an exercise regimen [12] . Low levels of oxidized LDL have been shown to activate many anti-atherogenic responses, including increased expression of catalase, haem oxygenase, MnSOD (manganese-dependent superoxide dismutase), GCL and endothelial NOS. [8, 9, [37] [38] [39] [40] [41] .
Summary
Oxidized lipids modulate a wide variety of cellular processes, including activating a variety of signalling pathways, some of which contribute to adaptive anti-atherogenic responses of the endothelium, whereas others promote apoptosis. The balance between these signalling pathways regulates processes that can be either apoptotic or cytoprotective, depending on the context. Electrophilic lipids, once thought to be only toxic by-products of lipid peroxidation, have been shown to play a critical role in mediating the adaptive response of endothelial cells. We are in the process of defining the electrophileresponsive proteome to provide the molecular basis of the distinction between adaptative and pro-apoptotic responses in the vasculature. We hypothesize that it is the activation of this adaptive response that contributes to the beneficial effects of exercise for cardiovascular health. It is interesting to speculate that the suppression of this adaptive response by inhibiting the low level formation of oxidized lipids could contribute to the failure of antioxidant intervention trials.
